ODR

ODR

ondansetron

Manufacturer:

Lapi
Concise Prescribing Info
Contents
Ondansetron
Indications/Uses
Management of nausea & vomiting induced by chemo- & radiotherapy or surgery.
Dosage/Direction for Use
IV Post-op vomiting & nausea 4 mg single dose IM or by slow IV inj. Nausea & vomiting induced by highly emetogenic chemotherapy Adult Initially 8 mg by slow IV inj or 15 min infusion given immediately before chemotherapy, followed by 1 mg by a constant infusion of 1 mg/hr for <24 hr or 2 inj of 8 mg by slow IV inj or 15 min infusion 4-hrly or alternatively, 8 mg orally twice daily for <5 days. Less emetogenic chemotherapy 8 mg by slow IV inj or 15 min infusion given immediately before chemotherapy, followed by 8 mg orally twice daily for <5 days. Childn <4 yr 5 mg/mL by 15 min IV infusion given immediately before chemotherapy, followed by 4 mg orally 12 hrly for <5 days. Syr Childn ≥11 yr 5 mL 3 times daily, may be increased to 10 mL. 4-11 yr 5 mL twice daily. 1-4 yr 0.15 mg/kg 3 times daily.
Special Precautions
Pregnancy & lactation.
Adverse Reactions
Headache, constipation, hot sensation on the head & epigastrum, sedation, diarrhea.
ATC Classification
A04AA01 - ondansetron ; Belongs to the class of serotonin (5HT3) antagonists. Used for the prevention of nausea and vomiting.
Presentation/Packing
Form
ODR inj 8 mg/2 mL
Packing/Price
5 × 1's (Rp175,000.00/boks)
Form
ODR syr 4 mg/5 mL
Packing/Price
1's (Rp85,000.00/botol)
Form
ODR inj 4 mg/2 mL
Packing/Price
(amp) 5 × 1's (Rp100,000.00/boks)
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Sign up for free
Already a member? Sign in